
                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Advanced Biotherapy, Inc. (the
"Company") on Form 10-QSB/A for the quarter ended June 30, 2006, as filed with
the Securities and Exchange Commission on the date hereof (the "Periodic
Report"), I, William M. Finkelstein, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

      1.    the Periodic Report fully complies with the requirements of Section
            13(a) or 15(d) of the Securities Exchange Act of 1934; and

      2.    the information contained in the Periodic Report fairly presents, in
            all material respects, the financial condition and results of
            operations of the Company.


Dated: August 23, 2006               /s/William M. Finkelstein
                                     -----------------------------------
                                     Chief Financial Officer

